← all works
What is the True Solubility Advantage for Amorphous Pharmaceuticals?
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- Pharmaceutical Research
- Topic
- Drug Solubulity and Delivery Systems
- Field
- Pharmacology, Toxicology and Pharmaceutics
- Canadian institutions
- Merck Canada Inc. (Canada)
- Funders
- Merck CanadaUniversity of Connecticut
- Keywords
- SolubilityAmorphous solidDifferential scanning calorimetryDissolutionMaterials scienceSupercoolingThermodynamicsGlass transitionHildebrand solubility parameterChemistryOrganic chemistryPolymerPhysics
- Has abstract in OpenAlex
- no